Member Login
  1. Stocks
    2. /
  2. Hikma Pharmaceuticals PLC (LSE: HIK)
    3. /

LSE:HIK (Hikma Pharmaceuticals PLC)

About HIK

Hikma is an international pharmaceutical company conducting operations through three businesses: generic pharmaceuticals, branded pharmaceuticals and injectable pharmaceuticals. The majority of Hikmas operations are in the United States, the Middle East and North Africa Region and Europe.
Financial Market Data copyright © 2024 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

    • Hikma Pharmaceuticals PLC (LSE: HIK) Latest News

    Investing Articles

    Are these two beaten-up FTSE 250 turnaround plays buys after today’s results?

    | Harvey Jones

    Harvey Jones says these FTSE 250 (INDEXFTSE:MCX) stocks could reward further investigation despite patchy results.

    Read more »

    Investing Articles

    Why I’d buy this FTSE 250 stock alongside AstraZeneca plc

    | Kevin Godbold

    I think AstraZeneca plc (LON: AZN) pairs well with this FTSE 250 (INDEXFTSE: MCX) player.

    Read more »

    Investing Articles

    2 growth stocks for the long run

    | Peter Stephens

    These two stocks could perform well in future years.

    Read more »

    Investing Articles

    2 turnaround stocks that could make you rich

    | Bilaal Mohamed

    Bilaal Mohamed picks out two battered pharmaceutical stocks that could turn out to be excellent recovery plays.

    Read more »

    Investing Articles

    There could be hidden value in these FTSE 250 stocks

    | G A Chester

    G A Chester discusses his two top-value picks from the FTSE 250 (INDEXFTSE:MCX).

    Read more »

    Investing Articles

    Why this battered pharma stock could be a top turnaround buy

    | Roland Head

    Roland Head selects his turnaround pick from two of this year's biggest pharma fallers.

    Read more »

    Investing Articles

    Hikma Pharmaceuticals plc’s pain could be GlaxoSmithKline plc’s gain

    | Zach Coffell

    Could ongoing approval issues at Hikma Pharmaceuticals plc (LON: HIK) and rivals help GlaxoSmithKline plc (LON:GSK) preserve its dividend?

    Read more »

    Airplane sitting on a runway
    Investing Articles

    These 2 battered stocks look set for a return to growth

    | Alan Oscroft

    These two hot recovery prospects certainly carry some risk, but they could provide great rewards for brave investors.

    Read more »

    Investing Articles

    2 FTSE 350 growth stocks I’d buy ASAP

    | G A Chester

    Now could be the perfect time to pick up shares in these two FTSE 350 (INDEXFTSE:NMX) growth companies.

    Read more »

    Investing Articles

    Are these bombed-out pharma stocks worth buying?

    | Rupert Hargreaves

    Should you catch these falling knives?

    Read more »

    Investing Articles

    2 ‘hot’ growth stocks I’d buy before it’s too late

    | Bilaal Mohamed

    Bilaal Mohamed explains why investors should consider these growth stocks before it's too late.

    Read more »

    Investing Articles

    Why I’d buy and hold Hikma Pharmaceuticals plc for the next decade

    | Peter Stephens

    Hikma Pharmaceuticals plc (LON: HIK) could be a stunning long-term growth stock.

    Read more »